Skip to main content


  • Monday, Aug 25th
    4:15 PM - 4:30 PM ET
    4F-01 - Sociodemographic and birth characteristics associated with initiation of recombinant growth hormone treatment in children: a nationwide study from 2010 to 2023
    Presenting Author: Sophie Billioti de Gage – EPI-PHARE (French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)), Saint-Denis, France
    Co-Author: Mahmoud Zureik, PhD, MD – EPI-PHARE Scientific Interest Group in Epidemiology of Health Products from the French National Agency for the Safety of Medicines and Health Products and the French National Health Insurance, St Denis, France ; Paris Saclay University, Université Versailles Saint Quentin (UVSQ - EDSP)
    Co-Author: Jean-Claude Carel – Pediatric Endocrinology-Diabetology Department, Reference Center for Rare Growth and Development Endocrine Diseases, INSERM NeuroDiderot, Assistance Publique-Hôpitaux de Paris, Université de Paris, Robert Debré University Hospital, 48 Bd Sérurier, 75019, Paris, France
    Co-Author: Alain Weill, PhD, MD – EPI-PHARE (French National Agency for Medicines and Health Products Safety (ANSM) and French National Health Insurance (CNAM)), Saint-Denis, France
    Pediatric Pharmacoepidemiology
  • Monday, Aug 25th
    4:30 PM - 4:45 PM ET
    4F-02 - Screening for Pediatric Safety Alerts Following Antipsychotic Treatment Initiation using a Tree-Based Scan Statistics Approach
    Presenting Author: Loreen Straub – Brigham and Women’s Hospital and Harvard Medical School
    Co-Author: Shirley V. Wang – Brigham and Women's Hospital, Harvard Medical School
    Co-Author: Kelly Fung – Brigham and Women's Hospital
    Co-Author: Helen Mogun – Brigham and Women’s Hospital and Harvard Medical School
    Co-Author: Massimiliano Russo, PhD, MS – Ohio State University
    Co-Author: Georg Hahn, PhD – Brigham and Women's Hospital
    Co-Author: Krista Huybrechts – Brigham and Women's Hospital and Harvard Medical School
    Pediatric Pharmacoepidemiology
  • Monday, Aug 25th
    4:45 PM - 5:00 PM ET
    4F-03 - National Trends in Psychotropic Medication Use, Psychotropic Polypharmacy, and Potential Drug-Drug Interactions Among US Children, Adolescents, and Young Adults
    Presenting Author: Lin-Chieh Meng – Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania
    Co-Author: Charles E. Leonard, PharmD, MSCE, FISPE – Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania
    Co-Author: Molly Candon – Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania
    Co-Author: David Mandell – Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania
    Co-Author: Sean Hennessy, PharmD, PhD – Center for Real-World Effectiveness and Safety of Therapeutics (CREST), Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania
    Pediatric Pharmacoepidemiology
  • Monday, Aug 25th
    5:00 PM - 5:15 PM ET
    4F-04 - Clinically Recognized Congenital Cytomegalovirus Infection and the Risk of Neurodevelopmental Disorders
    Presenting Author: Ahhyung Choi – Brigham and Women's Hospital and Harvard Medical School
    Co-Author: Timothy Savage, MD, MPH, MSc – Brigham and Women's Hospital / Boston Children's Hospital
    Co-Author: Krista Huybrechts – Brigham and Women's Hospital and Harvard Medical School
    Co-Author: Sonia Hernández-Díaz – Harvard T.H. Chan School of Public Health
    Co-Author: Brian Bateman – Stanford University School of Medicine
    Co-Author: Loreen Straub – Brigham and Women’s Hospital and Harvard Medical School
    Co-Author: Raisa Levin – Brigham and Women's Hospital and Harvard Medical School
    Co-Author: Yanmin Zhu, MS, PhD – Brigham and Women's Hospital and Harvard Medical School
    Pediatric Pharmacoepidemiology
  • Monday, Aug 25th
    5:15 PM - 5:30 PM ET
    4F-05 - Long-term benzodiazepine treatment among adolescents and young adults in the United States, 2017-2022
    Presenting Author: Zhuoyue Gou – Rutgers University
    Co-Author: Mark Olfson, MD, MPH – Columbia University
    Co-Author: Chintan Dave – Rutgers, the State University of New Jersey
    Co-Author: Hillary Samples – Rutgers University
    Co-Author: Tiansheng Wang, PharmD, PhD – Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill
    Co-Author: Greta Bushnell – Rutgers University
    Pediatric Pharmacoepidemiology
  • Monday, Aug 25th
    5:30 PM - 5:45 PM ET
    4F-06 - Antiemetic Use During Pregnancy and Child Neurodevelopmental Disorders: A Nationwide Birth Cohort Study
    Presenting Author: Yongtai Cho – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
    Co-Author: Eun-Young Choi – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea.
    Co-Author: Jung Yeol Han – Korea Mothersafe Counseling Center, Department of Obstetrics and Gynecology, Inje University Paik Hospital, Goyang, South Korea.
    Co-Author: Hoon Kim – Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.
    Co-Author: Young June Choe – Department of Pediatrics, Korea University Anam Hospital
    Co-Author: Ju-Young Shin, PharmD, PhD – School of Pharmacy, Sungkyunkwan University, Suwon, South Korea
    Pediatric Pharmacoepidemiology